Concateno bags another acquisition:
This article was originally published in Clinica
Executive Summary
UK drug and alcohol testing company Concateno continues to grow its maritime customer base with the acquisition of CPL International Serviced, a provider of alcohol and drugs-of-abuse screening services, as well as immunisation and medical examinations, to the maritime industry. Concateno bought CPL for a cash-and-stock consideration of £840,000 ($1.7m). Liverpool-based CPL, which recorded annual revenues of £433,000 in 2006, is Concateno's fifth purchase this year and comes one month after the latter acquired Marconova, a Swedish lab testing company also focused on the maritime industry, for £2m (see Clinica No 1258, p 14).
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.